In response to the ongoing ‘Nasha Mukti Bharat Abhiyan’ and under the clear directives of FDA Commissioner Manoj Kumar, the drug control administration (DCA) in Haryana conducted a significant and coordinated inspection operation in Sirsa district on
JB Chemicals and Pharmaceuticals, along with USV, are conducting a voluntary recall of antihistamine medications in the United States.
Pharmaceutical giant Sun Pharmaceutical Industries is anticipated to report consistent revenue growth, albeit with subdued profitability in its results for the September 2025 quarter (Q2FY26), impacted by increased costs associated with its US
The Subject Expert Committee (SEC) which is under the Central Drugs Standard Control Organization (CDSCO) has given the green signal to AstraZeneca India Pharma Limited’s application of Sodium Zirconium Cyclosilicate
Continuing its growth journey after the major investment in Hyderabad, Eli Lilly and Company now plans to build a USD 3 billion manufacturing facility in Katwijk, the Netherlands, within the Leiden Bio Science Park. The new site will increase...
Akums Drugs and Pharmaceuticals has made a major landmark by receiving a 20-year patent for its revolutionary 'tablet-in-tablet' technology aimed at treating Gastroesophageal Reflux Disease (GERD).
MedGenome, a leading global genomics-based diagnostics and research company, has made a majority investment in Gujarat-headquartered Green Cross Genetics Lab, strengthening its footprint in India’s growing diagnostics market...
Roche today reported positive Phase III results for Gazyva (obinutuzumab) in adults with systemic lupus erythematosus (SLE) receiving standard therapy. The ALLEGORY study met its main goal, showing more patients achieved a four-point improvement...
The World Health Organization (WHO) has published new guidelines for nations on how to mitigate the short-term and long-term consequences of abrupt and drastic cuts to external financing, which are interfering with the provision of critical health se
Cipla Ltd. had signed binding agreements to purchase the entire shareholding of Inzpera Healthscience Pvt. Ltd. for around Rs 110.65 crore.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")